Trading Signals: SONN Stock Price Prediction and Forecast (Mon. Aug. 24, 2015 - Thu. Apr. 30, 2020)(Sonnet BioTherapeutics Holdings, Inc.)
| SONN latest price $221.0000 (12.34%) ($187.4100 - $221.0000) on Mon. Feb. 22, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.27% (three month average) | RSI | 66 | Latest Price | $221.0000(12.34%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SONN advances 9.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support SONN advance at 0% a week (0% probability) IWC(16%) IWN(16%) QQQ(16%) SDY(16%) SKYY(16%) | Factors Impacting SONN price | SONN will decline at least -2.635% in a week (0% probabilities). VCSH(-25%) LQD(-20%) TLT(-18%) VCIT(-14%) CEMB(-14%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.635% (StdDev 5.27%) | Hourly BBV | 0 () | Intraday Trend | 13.3% | | | |
|
5 Day Moving Average | $211.2(4.64%) | 10 Day Moving Average | $199.66(10.69%) | 20 Day Moving Average | $191.35(15.5%) | To recent high | -24.8% | To recent low | 30.8% | Market Cap | $2.033b | | | | Sonnet BioTherapeutics Holdings, Inc. engages in the development of biologic drugs with enhanced single or bispecific mechanisms. Its technology utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. The company was founded on April 1, 2020 and is headquartered in Princeton, New Jersey. |